Premium
P83: QUALITY OF LIFE (QOL) ASSESSMENTS FOLLOWING THE USE OF PROPHYLACTIC C1 ESTERASE INHIBITOR CONCENTRATE IN PATIENTS WITH SEVERE HEREDITARY ANGIOEDEMA
Author(s) -
Merry A,
HeyworthSmith D,
Kennedy C,
Robertson S,
James L
Publication year - 2017
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.83_13578
Subject(s) - hereditary angioedema , medicine , angioedema , quality of life (healthcare) , c1 inhibitor , attendance , disease , pediatrics , dermatology , nursing , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom